Sustainability Report

Overview

The report describes Sinopharm's 2024 sustainability performance across governance, climate and workforce priorities. It reports Scope 1 emissions of 48,785.71 tons of CO2 equivalent, Scope 2 emissions of 177,259.36 tons, and a newly calculated partial Scope 3 inventory covering employee commuting and business travel. The company also completed its first carbon-neutral demonstration logistics park and reports 108,217 employees with 100% training participation. ESG oversight is assigned to the Board, supported by the Legal and Compliance and ESG Committee.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services